Adiponectin and AdipoR signaling were recently shown to play a promising role in various metabolic and age-associated neuropathological disorders because adiponectin enhances peripheral and central insulin sensitivity and prevents insulin resistance [65–68]. Here, ADIPOQ is linked to Insulin resistance.